Comparer des méthodes

	Échelle de Handicap de Sheehan (SDS)	Inventaire Rapide de la Symptomatologie Dépressive (QIDS)
Domaine	Psychologie clinique	Psychologie clinique
Famille	Process / pipeline	Process / pipeline
Année d'origine	1983	2003
Auteur d'origine	David V. Sheehan	A. John Rush
Type	Self-report questionnaire	Self-report or clinician-administered questionnaire
Source fondatrice	Sheehan, D. V. (1983). The Anxiety Disease. New York: Scribner. ISBN: 9780684183078	Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Ninan, P. T. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583.
Alias	SDS, Sheehan Disability Scale	QIDS, Quick Inventory of Depressive Symptomatology-Self Report, QIDS-SR
Apparentées	4	4
Résumé	The Sheehan Disability Scale is a brief three-item self-report measure designed by David V. Sheehan to assess functional impairment across work/school, social life, and family life domains in psychiatric and medical disorders. First described in Sheehan's 1983 book 'The Anxiety Disease' and validated in multiple studies since, the SDS quantifies the degree to which a patient's illness interferes with major life domains. It is widely used in psychiatric research and clinical practice to assess the functional impact of depression, anxiety, ADHD, and other conditions, complementing symptom severity measures by capturing real-world impairment.	The Quick Inventory of Depressive Symptomatology is a 16-item assessment designed by A. John Rush and colleagues to efficiently measure the severity of depressive symptoms in adults. Published in Biological Psychiatry in 2003, the QIDS exists in both self-report (QIDS-SR) and clinician-rated (QIDS-C) versions. It was developed as a brief alternative to the longer Inventory of Depressive Symptomatology (IDS, 30 items) while maintaining comprehensive coverage of DSM-IV depressive symptoms. The QIDS has become a standard outcome measure in treatment research, particularly in large comparative effectiveness trials.